Biotech Revolution

From Our Thought Leader's

Geoff Martha, CEO of Medtronic, Declares a Surge in Durable Mid-Single Digit Revenue Growth, Backed by Strong Fundamentals and Game-Changing Innovations

Medtronic plc announced financial results for its second quarter of fiscal year 2024 (FY24), which ended October 27, 2023. Key Highlights Revenue of $8.0 billion increased 5.3% as reported and 5.0% organic  GAAP diluted earnings per share (... Read more

22 November, 2023 | Wednesday | Company results
Bogota's Biopharma Breakthrough: A Strategic Dialogue with Isabella Muñoz, Executive Director of Invest In Bogota

In an exclusive interview with BioPharma BoardRoom, Isabella Muñoz, Executive Director of Invest In Bogota, shares insights into how Bogota has positioned itself as a thriving hub for the biopharmaceutical industry. From strategic advantages t... Read more

17 November, 2023 | Friday | Interview
Repligen CEO Tony Hunt Highlights ESG Success in 2022 Progress Report

Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the digital publication of its 2022 Sustainability Report and related reporting index disclosures. Themed “Making an Imp... Read more

15 November, 2023 | Wednesday | News
Novo Nordisk Executive Vice President, Henrik Wulff, Affirms Commitment with Significant Investment in New API Facility for Global Capacity Expansion

Novo Nordisk  announced plans to invest more than 42 billion Danish kroner starting in 20231 to expand existing manufacturing facilities in Kalundborg, Denmark, for the current and future product portfolio within serious chronic diseases. The i... Read more

13 November, 2023 | Monday | News

Bio Finance

Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink

Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, announced that its wholly owned subsidiary, Orion Acquisition AB (the “Buyer”), has extended the expiration time of the offering... Read more

04 December, 2023 | Monday | News
Perpetual Medicines Raises $8M in Seed Round for Peptide Drug Discovery Platform

Perpetual Medicines  announced it has closed an $8 million seed financing to advance its integrated computational design and synthesis platform for peptide drug discovery. The financing round was led by Chengwei Capital. The company also anno... Read more

04 December, 2023 | Monday | News

Contract Services

Merck Expands Newest Biologics Testing Center in Shanghai

Further develops its biosafety testing laboratories to meet local demand New labs complete 2nd phase of company’s € 29 million Biologics Testing Center opened in 2022 Enhances BioReliance® testing services portfolio in the Chinese ... Read more

29 November, 2023 | Wednesday | News
Hovione Acquires ExtremoChem for Biopharmaceutical Stabilization and Delivery

Hovione has acquired ExtremoChem Lda, a start-up company with a portfolio of rare sugars, synthetic analogues of the natural molecules found in extremophiles. The acquisition provides Hovione with new high-performance func... Read more

17 November, 2023 | Friday | News

BioPharma Video

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2023 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in